zoledronic acid has been researched along with Cognitive Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Churilla, BM; Greenspan, SL; Kotlarczyk, MP; Perera, S; Resnick, NM | 1 |
| Aydogdu, A; Bozoglu, E; Cintosun, U; Doruk, H; Meric, C; Naharci, I; Safer, U; Tasci, I | 1 |
1 trial(s) available for zoledronic acid and Cognitive Dysfunction
| Article | Year |
|---|---|
Zoledronic acid and bone health in older adults with cognitive impairment.
Topics: Aged; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Cognitive Dysfunction; Collagen Type I; Diphosphonates; Double-Blind Method; Female; Femur Neck; Humans; Imidazoles; Zoledronic Acid | 2022 |
1 other study(ies) available for zoledronic acid and Cognitive Dysfunction
| Article | Year |
|---|---|
Zoledronic Acid Use and Risk of Cognitive Decline among Elderly Women and Men with Osteoporosis.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Cognitive Dysfunction; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Male; Osteoporosis; Prospective Studies; Zoledronic Acid | 2016 |